Last Posted: Jun 13, 2020
- Aspirin for Lynch syndrome: a legacy of prevention
MB Yurgelun et al, The Lancet, June 13, 2020 - Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
J Burn et al, The Lancet June 13, 2020 - Cost-Effectiveness of the Manchester Approach to Identifying Lynch Syndrome in Women with Endometrial Cancer.
Snowsill Tristan M et al. Journal of clinical medicine 2020 Jun 9(6) - Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
Vos Janet R et al. International journal of cancer 2020 Jun - Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD).
Seppälä Toni T et al. Familial cancer 2020 Jun - Underutilization of Lynch Syndrome Screening at Two Large Veterans Affairs Medical Centers.
Mittal Chetan et al. Digestive diseases and sciences 2020 Jun - Implementation of Universal Tumor Screening of Colorectal Cancer for Detection of Lynch Syndrome at a Hispanic-Rich County Hospital.
Snedden Tyler W et al. JCO oncology practice 2020 May JOP1900508 - Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study.
Bucksch Karolin et al. BMC cancer 2020 May 20(1) 460 - Cancer-risk by family history and mismatch-repair mutation in Lynch syndrome.
Marques-de-Sá Inês et al. Scandinavian journal of gastroenterology 2020 May 1-5 - Risk factors for metachronous colorectal cancer in Lynch syndrome patients: a registry-based observational mono-institutional study cohort.
Signoroni Stefano et al. International journal of clinical oncology 2020 May
No hay comentarios:
Publicar un comentario